| LINE ITEM (USD / %) | FY 2025
FILED 2026-04-30 | FY 2024
FILED 2025-04-30 | FY 2023
FILED 2024-04-30 |
|---|---|---|---|
| Revenue (Total Sales) | $2.94B | $2.76B | $2.80B |
| YoY Revenue Growth % | +6.4% | -1.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $374.7M | $346.3M | $212.9M |
| Operating Margin % | 12.8% | 12.5% | 7.6% |
| Net Income (GAAP) | $280.8M | $251.1M | $172.6M |
| EBITDA (Normalized) | $446.7M | $396.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $414.2M | $364.4M | $284.0M |
| Capital Expenditures (CapEx) | $89.9M | $62.5M | — |
| Free Cash Flow (FCF) | $324.3M | $301.9M | $284.0M |
| FCF Margin % | 11.0% | 10.9% | 10.2% |
| Return on Invested Capital (ROIC %) | 20.2% | 19.4% | — |
| Cash & Short-Term Equivalents | $938.4M | $779.3M | — |
| Total Debt (Short + Long Term) | $398.4M | $397.5M | — |
| Total Stockholders' Equity | $2.00B | $1.79B | — |